Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ...
Iovance Biotherapeutics guides for $350M–$370M 2026 revenue with Q2'26 expected to be a record Amtagvi quarter. Read more on ...
Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter ...
Morning Overview on MSN
Doctors say a few routine blood tests can flag trouble years before symptoms appear
Millions of patients walk out of primary-care offices each year with lab results that read “normal” while early signs of ...
Morning Overview on MSN
5 jobs people now hand to AI assistants, and where they still go wrong
Professionals across white-collar industries are offloading first drafts, code suggestions, data summaries, customer replies, ...
Introduction Autistic children can experience elevated levels of emotional and behavioural problems, which adversely impact their psychosocial functioning. Positive parenting behaviours can ...
Qure N.V. rallies as FDA accepts AMT-130 Phase 1/2 data for accelerated approval in Huntington’s. Click for this QURE stock ...
For decades it has been debated in total knee arthroplasty what strategy for the patella is superior. Resurfacing in all ...
Biology has clever ways to mask the effects of potentially harmful gene mutations. Scientists are investigating how this ...
Introduction Cannabis use is common in the USA and is associated with adverse outcomes across many domains, including sleep difficulties. Targeting insomnia with an evidence-based treatment could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results